A new gold star for cancer care at CPMC: Accreditation by the American College of Surgeons National Accreditation Program for Rectal Cancer
SAN FRANCISCO – Calif. More than 40,000 people in the United States develop rectal cancer each year and it is the second most common cause of cancer deaths. Fortunately, research has made inroads for colorectal cancer—including the development of targeted therapies that more precisely treat the disease.
Cancer patients treated at Sutter’s California Pacific Medical Center (CPMC) benefit from leading-edge research, compassionate care, and the opportunity to enroll in clinical trials of the latest therapies for cancers at all stages of the illness.
With the news that CPMC was recently recognized by the National Accreditation Program for Rectal Cancer (NAPRC) as a leading Center of Excellence, cancer patients have another reason to be assured high-quality care informed by the latest research.
“We are committed to providing our patients the best care and comfort possible, from diagnosis through treatment and survivorship,” says Ari Baron, M.D., chief, Division of Hematology Oncology, CPMC. “I’m tremendously proud of our multidisciplinary team and our collective work in meeting these important clinical standards recognized by the NAPRC.”
CPMC is the ninth institution in the country to be accredited and one of only three Northern California hospitals accredited by the NAPRC, a program launched in 2017 and administered by the American College of Surgeons.
To earn the three-year accreditation, CPMC met 19 standards, including the establishment of a rectal cancer multidisciplinary team that includes clinical representatives from surgery, pathology, radiology, radiation oncology and medical oncology.
Thirteen of those standards address clinical services that the program was required to provide, including CEA testing (which detects “carcinoembryonic antigen,” a marker of rectal cancer and other cancers), magnetic resonance imaging and computerized tomography imaging for cancer staging, and ensuring a process whereby the patient starts treatment within a defined timeframe. The standards also require that rectal cancer patients’ treatment is prospectively discussed by a multi-disciplinary care team.
“CPMC has a long tradition of providing advanced cancer care with a personalized approach,” says Michael Abel, M.D., FACS, FASCRS, chair of the Department of Surgery, and director of the Colorectal Cancer Center of Excellence Program at CPMC. “Our nationally recognized cancer specialists, highly trained oncology nurses and skilled technicians work together so patients have access to leading-edge treatments, appropriate clinical trials and a multidisciplinary support team.”
About the National Accreditation Program for Rectal Cancer:
The NAPRC was developed through a collaboration between the ACS Commission on Cancer (CoC), an ACS quality program, and the Optimizing the Surgical Treatment of Rectal Cancer (OSTRiCh) Consortium, as well as the American College of Radiology (ACR), the American Society of Colon and Rectal Surgeons (ASCRS), and the College of American Pathologists (CAP). It is based on successful international models that emphasize program structure, patient care processes, performance improvement, and performance measures. Its goal is to ensure that rectal cancer patients receive appropriate care using a multidisciplinary approach.